Viewing Study NCT05515120

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-01-10 @ 4:17 AM
Study NCT ID: NCT05515120
Status: COMPLETED
Last Update Posted: 2022-08-25
First Post: 2022-08-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
Sponsor: Instituto Mexicano del Seguro Social
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Venous Thromboembolism View
None Anticoagulant-induced Bleeding View
None Venous Thromboses View
None Pulmonary Embolism View
Keywords:

Keywords

Keyword Brief Keyword Text View
None venous thromboembolism View
None Rivaroxaban View
None Aspirin View
None Acenocoumarol View